Surmodics Inc
NASDAQ:SRDX
Surmodics Inc
Tax Provision
Surmodics Inc
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Surmodics Inc
NASDAQ:SRDX
|
Tax Provision
-$4.7m
|
CAGR 3-Years
-56%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Tax Provision
-$233m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-38%
|
CAGR 10-Years
2%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Tax Provision
-$436m
|
CAGR 3-Years
-130%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Tax Provision
-$499m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
3%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Tax Provision
$6.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Tax Provision
-$336.3m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-10%
|
|
Surmodics Inc
Glance View
Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. The company is headquartered in Eden Prairie, Minnesota and currently employs 389 full-time employees. The firm operates through two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices, as well as drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that includes coronary, peripheral, neurovascular and structural heart, among others. The IVD segment designs, develops and manufactures component products and technologies for diagnostic immunoassay, as well as molecular tests and biomedical research applications, with products that include protein stabilization reagents, substrates, surface coatings and antigens.
See Also
What is Surmodics Inc's Tax Provision?
Tax Provision
-4.7m
USD
Based on the financial report for Dec 31, 2024, Surmodics Inc's Tax Provision amounts to -4.7m USD.
What is Surmodics Inc's Tax Provision growth rate?
Tax Provision CAGR 10Y
3%
Over the last year, the Tax Provision growth was -10%. The average annual Tax Provision growth rates for Surmodics Inc have been -56% over the past three years , and 3% over the past ten years .
You don't have any saved screeners yet